These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 31811950)
21. Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival Among Patients With Stage III Colon Cancer: The CALGB/SWOG 80702 (Alliance) Randomized Clinical Trial. Meyerhardt JA; Shi Q; Fuchs CS; Meyer J; Niedzwiecki D; Zemla T; Kumthekar P; Guthrie KA; Couture F; Kuebler P; Bendell JC; Kumar P; Lewis D; Tan B; Bertagnolli M; Grothey A; Hochster HS; Goldberg RM; Venook A; Blanke C; O'Reilly EM; Shields AF JAMA; 2021 Apr; 325(13):1277-1286. PubMed ID: 33821899 [TBL] [Abstract][Full Text] [Related]
22. Duration of Adjuvant Chemotherapy for Stage III Colon Cancer. Grothey A; Sobrero AF; Shields AF; Yoshino T; Paul J; Taieb J; Souglakos J; Shi Q; Kerr R; Labianca R; Meyerhardt JA; Vernerey D; Yamanaka T; Boukovinas I; Meyers JP; Renfro LA; Niedzwiecki D; Watanabe T; Torri V; Saunders M; Sargent DJ; Andre T; Iveson T N Engl J Med; 2018 Mar; 378(13):1177-1188. PubMed ID: 29590544 [TBL] [Abstract][Full Text] [Related]
23. New approaches to assessing and treating early-stage colon and rectal cancers: cooperative group strategies for assessing optimal approaches in early-stage disease. Benson AB Clin Cancer Res; 2007 Nov; 13(22 Pt 2):6913s-20s. PubMed ID: 18006800 [TBL] [Abstract][Full Text] [Related]
24. Outcomes among African-Americans and Caucasians in colon cancer adjuvant therapy trials: findings from the National Surgical Adjuvant Breast and Bowel Project. Dignam JJ; Colangelo L; Tian W; Jones J; Smith R; Wickerham DL; Wolmark N J Natl Cancer Inst; 1999 Nov; 91(22):1933-40. PubMed ID: 10564677 [TBL] [Abstract][Full Text] [Related]
25. Physical Activity and Outcomes in Patients with Stage III Colon Cancer: A Correlative Analysis of Phase III Trial NCCTG N0147 (Alliance). Phipps AI; Shi Q; Zemla TJ; Dotan E; Gill S; Goldberg RM; Hardikar S; Jahagirdar B; Limburg PJ; Newcomb PA; Shields A; Sinicrope FA; Sargent DJ; Alberts SR Cancer Epidemiol Biomarkers Prev; 2018 Jun; 27(6):696-703. PubMed ID: 29563133 [No Abstract] [Full Text] [Related]
26. Adjuvant therapy for completely resected stage II colon cancer. Figueredo A; Coombes ME; Mukherjee S Cochrane Database Syst Rev; 2008 Jul; 2008(3):CD005390. PubMed ID: 18646127 [TBL] [Abstract][Full Text] [Related]
27. Risk of recurrence in patients with colon cancer stage II and III: a systematic review and meta-analysis of recent literature. Böckelman C; Engelmann BE; Kaprio T; Hansen TF; Glimelius B Acta Oncol; 2015 Jan; 54(1):5-16. PubMed ID: 25430983 [TBL] [Abstract][Full Text] [Related]
28. Alcohol consumption and colon cancer prognosis among participants in north central cancer treatment group phase III trial N0147. Phipps AI; Shi Q; Limburg PJ; Nelson GD; Sargent DJ; Sinicrope FA; Chan E; Gill S; Goldberg RM; Kahlenberg M; Nair S; Shields AF; Newcomb PA; Alberts SR; Int J Cancer; 2016 Sep; 139(5):986-95. PubMed ID: 27060850 [TBL] [Abstract][Full Text] [Related]
29. DPYD variants as predictors of 5-fluorouracil toxicity in adjuvant colon cancer treatment (NCCTG N0147). Lee AM; Shi Q; Pavey E; Alberts SR; Sargent DJ; Sinicrope FA; Berenberg JL; Goldberg RM; Diasio RB J Natl Cancer Inst; 2014 Dec; 106(12):. PubMed ID: 25381393 [TBL] [Abstract][Full Text] [Related]
30. Analysis of Molecular Markers by Anatomic Tumor Site in Stage III Colon Carcinomas from Adjuvant Chemotherapy Trial NCCTG N0147 (Alliance). Sinicrope FA; Mahoney MR; Yoon HH; Smyrk TC; Thibodeau SN; Goldberg RM; Nelson GD; Sargent DJ; Alberts SR; Clin Cancer Res; 2015 Dec; 21(23):5294-304. PubMed ID: 26187617 [TBL] [Abstract][Full Text] [Related]
31. Long-term survival results of surgery alone versus surgery plus 5-fluorouracil and leucovorin for stage II and stage III colon cancer: pooled analysis of NSABP C-01 through C-05. A baseline from which to compare modern adjuvant trials. Wilkinson NW; Yothers G; Lopa S; Costantino JP; Petrelli NJ; Wolmark N Ann Surg Oncol; 2010 Apr; 17(4):959-66. PubMed ID: 20082144 [TBL] [Abstract][Full Text] [Related]
32. KRAS and BRAF Mutations in Stage II and III Colon Cancer: A Systematic Review and Meta-Analysis. Formica V; Sera F; Cremolini C; Riondino S; Morelli C; Arkenau HT; Roselli M J Natl Cancer Inst; 2022 Apr; 114(4):517-527. PubMed ID: 34542636 [TBL] [Abstract][Full Text] [Related]
33. Marine omega-3 fatty acid intake and survival of stage III colon cancer according to tumor molecular markers in NCCTG Phase III trial N0147 (Alliance). Song M; Ou FS; Zemla TJ; Hull MA; Shi Q; Limburg PJ; Alberts SR; Sinicrope FA; Giovannucci EL; Van Blarigan EL; Meyerhardt JA; Chan AT Int J Cancer; 2019 Jul; 145(2):380-389. PubMed ID: 30623420 [TBL] [Abstract][Full Text] [Related]
34. Outcomes and toxicity in african-american and caucasian patients in a randomized adjuvant chemotherapy trial for colon cancer. McCollum AD; Catalano PJ; Haller DG; Mayer RJ; Macdonald JS; Benson AB; Fuchs CS J Natl Cancer Inst; 2002 Aug; 94(15):1160-7. PubMed ID: 12165641 [TBL] [Abstract][Full Text] [Related]
35. DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-fluorouracil-based adjuvant therapy. Sinicrope FA; Foster NR; Thibodeau SN; Marsoni S; Monges G; Labianca R; Kim GP; Yothers G; Allegra C; Moore MJ; Gallinger S; Sargent DJ J Natl Cancer Inst; 2011 Jun; 103(11):863-75. PubMed ID: 21597022 [TBL] [Abstract][Full Text] [Related]
36. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? Gill S; Loprinzi CL; Sargent DJ; Thomé SD; Alberts SR; Haller DG; Benedetti J; Francini G; Shepherd LE; Francois Seitz J; Labianca R; Chen W; Cha SS; Heldebrant MP; Goldberg RM J Clin Oncol; 2004 May; 22(10):1797-806. PubMed ID: 15067028 [TBL] [Abstract][Full Text] [Related]
37. Family history of colorectal cancer and its impact on survival in patients with resected stage III colon cancer: results from NCCTG Trial N0147 (Alliance). Jansson-Knodell CL; Foster NR; Sargent DJ; Limburg PJ; Thibodeau SN; Smyrk TC; Sinicrope FA; Jahagirdar B; Goldberg RM; Alberts SR J Gastrointest Oncol; 2017 Feb; 8(1):1-11. PubMed ID: 28280603 [TBL] [Abstract][Full Text] [Related]
38. Association Between Adjuvant Chemotherapy Duration and Survival Among Patients With Stage II and III Colon Cancer: A Systematic Review and Meta-analysis. Boyne DJ; Cuthbert CA; O'Sullivan DE; Sajobi TT; Hilsden RJ; Friedenreich CM; Cheung WY; Brenner DR JAMA Netw Open; 2019 May; 2(5):e194154. PubMed ID: 31099875 [TBL] [Abstract][Full Text] [Related]
39. Randomized trial of adjuvant therapy in colon carcinoma: 10-year results of NSABP protocol C-01. Smith RE; Colangelo L; Wieand HS; Begovic M; Wolmark N J Natl Cancer Inst; 2004 Aug; 96(15):1128-32. PubMed ID: 15292384 [TBL] [Abstract][Full Text] [Related]
40. Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study. André T; de Gramont A; Vernerey D; Chibaudel B; Bonnetain F; Tijeras-Raballand A; Scriva A; Hickish T; Tabernero J; Van Laethem JL; Banzi M; Maartense E; Shmueli E; Carlsson GU; Scheithauer W; Papamichael D; Möehler M; Landolfi S; Demetter P; Colote S; Tournigand C; Louvet C; Duval A; Fléjou JF; de Gramont A J Clin Oncol; 2015 Dec; 33(35):4176-87. PubMed ID: 26527776 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]